Filing Details
- Accession Number:
- 0001140859-23-000132
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-22 16:03:22
- Reporting Period:
- 2023-09-21
- Accepted Time:
- 2023-09-22 16:03:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1140859 | Cencora Inc. | COR | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 233079390 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1784795 | E Leslie Donato | 1 West First Avenue Conshohocken PA 19428 | Evp & Chief Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-21 | 3,386 | $86.09 | 8,736 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-09-21 | 3,386 | $185.00 | 5,350 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2023-09-21 | 3,386 | $0.00 | 3,386 | $86.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,387 | 2026-11-13 | No | 4 | M | Direct |
Footnotes
- The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023.
- Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23.
Billionaire Hedge Funds
